CTRA vs STRO · P/E 15, rev $5.46B vs rev $62.0M
Coterra Energy Inc (CTRA) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Coterra Energy Inc (CTRA) is a oil & gas e&p company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported CTRA revenue for 2024-12-31 was $5.46B. Net income was $1.12B. Revenue was down 7.7% from 2023-12-31 to 2024-12-31. CTRA currently screens at market cap $20.46B and trailing P/E 15.2.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
CTRA currently screens at market cap $20.46B and trailing P/E 15.2. STRO currently screens at market cap $470.8M.
Not investment advice. Open the CTRA and STRO stock pages for the full models.
Not investment advice.